Showing Results for: “Glycemic Index and Diabetes”

Exploratory Analysis from the SURPASS-4 Trial Data for Kidney Function with Tirzepatide Compared to Insulin Glargine A pre-specified exploratory analysis from the SURPASS-4 trial showed tirzepatide, a novel once-weekly medication for the treatment of diabetes, improved kidney outcomes for adults with type 2 diabetes who have increased cardiovascular risk. SURPASS-4 was part of the SURPASS global clinical development program for Eli Lilly and Company’s tirzepatide. Findings were presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Chronic kidney disease (CKD)

The American Diabetes Association (ADA) unveils this year’s National Scientific and Health Care Achievement Award recipients The American Diabetes Association ® (ADA) is thrilled to announce the recipients of the 2022 National Scientific and Health Care Achievement Awards . The awards honor academics, health care providers, and educators who have contributed to substantial advances in the field of diabetes care and research. With the help of these leaders and their steadfast dedication, we move closer to achieving the mission of the ADA: a life free of diabetes and all its burdens. “These

Tonight, President Biden urged in his State of the Union address that Congress take immediate action to finally address the prohibitive cost of insulin for people living with diabetes. The American Diabetes Association ® (ADA) joins this call on Congress to take swift action and pass legislation to cap monthly out-of-pocket insulin costs at $35 for Americans with commercial insurance, group health plans, and Medicare. The ADA has led the campaign resulting in the enactment of state-level out-of-pocket limits for insulin in 20 states and the District of Columbia. We've seen exactly how much

The American Diabetes Association ® (ADA) is excited to announce the return to in-person ADA Camps for the Summer season of 2022, with staggered registration beginning on February 16, 2022. “Young people have gone through a lot during the pandemic, and the ADA knows it is vitally important to get children back to doing what they do best–meeting new friends and enjoying activities together in a safe environment,” said Charles D. Henderson, Chief Development Officer of the ADA. “Our ADA Camps offer a traditional summer camp experience, while giving children the chance to develop basic diabetes

The American Diabetes Association ® (ADA) today released the following statement regarding the updated data from the National Diabetes Statistics Report provided by the Centers for Disease Control and Prevention (CDC) on the number of adults living in the U.S. with diabetes and prediabetes: "The new CDC data show an alarming increase of diabetes in our nation among adults, with 133 million Americans now living with diabetes or prediabetes, which is an increase of 11 million more Americans . Even more concerning, of those 133 million Americans, there are 96 million adults in the U.S. who

The American Diabetes Association ® (ADA) welcomes the 2022 Principal Officers and Board of Directors. The 13-member board is comprised of forward-thinking, innovative medical, scientific, education and executive business professionals, who will strategically lead and focus efforts to ensure the ADA continues to uphold the mission upon which it was founded. "We are so excited to announce our 2022 Board of Directors, including four new Board members,” said ADA’s Office of the CEO. “We look forward to the insight and skills that each of these thought leaders will provide to help move the needle

Prevalence of diabetes disproportionately impacted lower-income populations; highlights the need for increased prevention strategies A new study from researchers at the Centers for Disease Control and Prevention (CDC) reveal income-related inequalities (IRI) in rates of diabetes exist between 2001 and 2018. The findings were presented at the virtual 81st Scientific Sessions held by the American Diabetes Association ® (ADA). Throughout the U.S., diabetes prevalence has increased over the past two decades, disproportionately affecting low-income populations. For example, between 2011 and 2014

The American Diabetes Association ® (ADA) is thrilled to announce the recipients of the 2023 National Scientific and Health Care Achievement Awards . The awards honor academics, health care providers, and educators who have contributed to substantial advances in the field of diabetes care and research. With the help of these leaders and their steadfast dedication, we move closer to achieving the mission of the ADA: To prevent and cure diabetes and to improve the lives of all people affected by diabetes. “The ADA’s National Scientific and Health Care Achievement Awards honor those who have made

The American Diabetes Association ® (ADA) welcomes the 2023 Principal Officers and Board of Directors. The 13-member board is comprised of forward-thinking, innovative medical, scientific, education, and executive business professionals, who will strategically lead and focus efforts to ensure the ADA continues to uphold the mission upon which it was founded. "We are so excited to announce our 2023 Board of Directors,” said Charles Henderson, CEO of the ADA. “We look forward to the insight and skills that each of these thought leaders will provide to help move the needle and improve the lives

Today, the U.S. Food & Drug Administration (FDA) officially moved insulin to the biologic regulatory framework. All insulins on the market have officially been deemed biologics by the FDA—paving the way for biosimilar and interchangeable insulins. Learn more about what this change means for people living with diabetes at diabetes.org/biologics . LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs & Advocacy for the American Diabetes Association (ADA), issued the following statement: "Insulin is life-sustaining for about seven million Americans—too many of whom can’t afford it